Corticosteroid in the treatment of moderate to severe thrombocytopenia due to leptospirosis
Joint Authors
Alian, Shahriar
Asghari, Hasan
Najafi, Nargis
Davoudi, Alireza
Yazdani, Jamshid
Source
Iranian Red Crescent Medical Journal
Issue
Vol. 16, Issue 10 (31 Oct. 2014), pp.1-6, 6 p.
Publisher
Publication Date
2014-10-31
Country of Publication
United Arab Emirates
No. of Pages
6
Main Subjects
Topics
Abstract EN
Background : Thrombocytopenia is associated with a bad prognosis in Leptospirosis.
Objectives : We investigated the effect of corticosteroids to improve thrombocytopenia due to leptospirosis.
Patients and Methods : In a clinical trial, all patients admitted with leptospirosis in Razi Hospital of Ghaemshahr, north of Iran were enrolled in a 2-year study.
Totally, 56 patients with moderate to severe thrombocytopenia were randomized to control and treatment groups.
The treatment group received corticosteroid (prednisolone 1 mg / kg / day for maximum one week) in addition to the standard antibiotic therapy.
Results : There was no significant difference regarding age and gender between the two groups (P = 0.254, P = 0.789, respectively).
The mean duration to improve thrombocytopenia was 4.41 ± 0.197 days in the treatment group and 5.72 ± 0.318 days in the control group, which was significantly different (P = 0.003).
Duration of hospitalization in the treatment group was 5.24 ± 0.244 days and 6.23 ± 0.329 days in the control group, which was significantly different (P = 0.028).
The two groups had no significant difference regarding mortality, intubation, level of platelet, duration of ICU admission and pulmonary, renal or hepatic involvement.
Conclusions : Corticosteroid therapy decreased the length of hospitalization only in severe subgroup thrombocytopenia, but not in the moderate subgroup.
American Psychological Association (APA)
Alian, Shahriar& Asghari, Hasan& Najafi, Nargis& Davoudi, Alireza& Yazdani, Jamshid. 2014. Corticosteroid in the treatment of moderate to severe thrombocytopenia due to leptospirosis. Iranian Red Crescent Medical Journal،Vol. 16, no. 10, pp.1-6.
https://search.emarefa.net/detail/BIM-416817
Modern Language Association (MLA)
Alian, Shahriar…[et al.]. Corticosteroid in the treatment of moderate to severe thrombocytopenia due to leptospirosis. Iranian Red Crescent Medical Journal Vol. 16, no. 10 (Oct. 2014), pp.1-6.
https://search.emarefa.net/detail/BIM-416817
American Medical Association (AMA)
Alian, Shahriar& Asghari, Hasan& Najafi, Nargis& Davoudi, Alireza& Yazdani, Jamshid. Corticosteroid in the treatment of moderate to severe thrombocytopenia due to leptospirosis. Iranian Red Crescent Medical Journal. 2014. Vol. 16, no. 10, pp.1-6.
https://search.emarefa.net/detail/BIM-416817
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references : p. 5-6
Record ID
BIM-416817